Neoadjuvant Triprizumab and Radiotherapy in Operable Patients With Stage IIA-IIIA Non-small Cell Lung Cancer

Conditions: Non-small Cell Lung Cancer; Neoadjuvant Therapy; Radiotherapy; Immunotherapy Interventions: Drug: Toripalimab; Radiation: Conventional segmental radiotherapy; Other: opreation Sponsors: Northern Jiangsu Province People ' s Hospital; Shanghai Junshi Bioscience Co., Ltd. Recruiting

https://clinicaltrials.gov/study/NCT06065813

Source: ClinicalTrials.gov - October 4, 2023 Category: Research Source Type: clinical trials